市場調査レポート
商品コード
1255232
がん遺伝子治療市場 - 世界の産業規模、シェア、動向、機会、予測、2018-2028年、療法別、適応症別、エンドユーザー別、地域別、競合Cancer Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Therapy, By Indication, By End User, By Region, and Competition |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
がん遺伝子治療市場 - 世界の産業規模、シェア、動向、機会、予測、2018-2028年、療法別、適応症別、エンドユーザー別、地域別、競合 |
出版日: 2023年04月01日
発行: TechSci Research
ページ情報: 英文 113 Pages
納期: 2~3営業日
|
がん遺伝子治療の世界市場は、予測期間中に目覚ましい成長を遂げると予想されています。
低費用で痛みの少ない治療に対する需要の高まりと、人々の美意識の高まりが、世界のさまざまな地域でがん遺伝子治療の需要を大きく高めています。また、遺伝子治療や診断の利点に関する意識の高まりや、世界のがん治療に対するヘルスケア支出の増加も、予測期間中のがん遺伝子治療市場をさらに後押しすると予想されます。2022年、米国では推定66,470人(男性48,520人、女性17,950人)が頭頸部がんと診断される見込みです。
研究開発活動の活発化とヘルスケアインフラの整備による技術進歩が、予測期間中のがん遺伝子治療市場成長の主な要因となっています。政府機関は、より高い利益を得るために、開発されたインフラに焦点を当てています。倫理的に許容されるがん治療には、さまざまなタイプの革新的な治療法が用意されており、新製品の開発が進んでいることも、長年にわたって市場の成長を後押しすると期待されます。規制環境の整備は、がん遺伝子治療の需要を高め、予測期間中の市場成長を後押しすると思われます。消費者の健康に直結するため、欠陥のない製品の発売を保証するために、生産者に規制がかけられており、これが長年にわたって市場の成長を促進する可能性があります。遺伝子治療製品に欠陥があれば、患者さんにとって悲惨なことになりかねないため、市販後調査中の製品回収を防ぐために、いくつかの法律が改正されました。しかし、今後数年間のがん遺伝子治療市場の拡大は、高品質のがん遺伝子治療の利用可能性が高まっていることに助けられるでしょう。2020年には、米国の女性において、新たに276,480例の浸潤性乳がんが診断されるとともに、新たに48,530例の非浸潤性(in situ)乳がんが診断されると推定されます。
人口増加による糖尿病や肥満などの生活習慣病の有病率の増加、過剰なアルコール摂取、タバコの使用、低運動量、高体重指数、果物や野菜の低摂取は、さらに予測期間中に市場の有利な成長を生み出すと予想されます。2022年3月、国立心肺血液研究所は、インディアナ大学医学部研究者に1,200万米ドルを付与しました。この助成金は、血友病の治療法としてより安全で治癒の可能性がある遺伝子治療アプローチの主要部分を開発するためのものです。このように、さまざまな民間企業や政府機関が、世界中のがん疾患を治すために遺伝子治療に投資しています。同様に、ラボラトリーオートメーションに対する需要の増加や予防ヘルスケアに対する意識の高まりは、長年にわたって市場の成長を後押しする主な要因となっています。がん患者の増加は、世界で2番目に大きな死因であることから、主に業界の成長に影響を及ぼしています。2020年には、米国で新たに1,806,590人のがん患者が診断され、606,520人がこの病気で死亡すると推定されています。
与えられた市場データをもとに、TechSci Researchは企業の特定のニーズに応じてカスタマイズを提供します。本レポートでは、以下のカスタマイズが可能です:
The Global Cancer Gene Therapy Market is anticipated to witness impressive growth during the forecast period. Growing demand for painless treatment at lower cost coupled with increasing aesthetic consciousness among the population significantly increases the demand for cancer gene therapy across different parts of the globe. Besides, growing awareness about the advantages of using gene therapy and diagnosis, along with increasing healthcare expenditure on cancer treatment across the globe, is further expected to support the Cancer Gene Therapy Market during the forecast period. In 2022, an estimated 66,470 people (48,520 men and 17,950 women) will be diagnosed with head and neck cancer in the United States.
Increasing research and development activities and technological advancement with developed healthcare infrastructure is the major factor for the growth of the cancer gene therapy market during the forecast period. Government organizations are focusing on developed infrastructure with higher profit. Different type of innovative therapies is available for cancer therapy which is ethically acceptable, and the increasing development of new products are expected to boost the market growth over the years. The growing regulatory environment has enhanced the demand for cancer gene therapy which will boost market growth during the forecast period. Due to their direct connection to consumer health, regulations are placed on producers to assure the release of products that are free from flaws which can drive market growth over the years. Some laws have been changed to prevent product recalls during post-marketing surveillance since any flaws in gene therapy goods could be disastrous for patients. However, the expansion of the cancer gene therapy market in the years to come will be aided by the growing availability of high-quality cancer gene therapy. In 2020, an estimated 276,480 new cases of invasive breast cancer will be diagnosed in women in the U.S. as well as 48,530 new cases of non-invasive (in situ) breast cancer.
The increasing prevalence rate of lifestyle disorders such as diabetes and obesity, excessive alcohol consumption, tobacco use, low physical activity, high body mass index, and low intake of fruits and vegetables because of the growing population is further expected to create a lucrative growth of the market during the forecast period. In march 2022, the National Heart, Lung, and Blood Institute granted USD 12 million to an Indiana University School of Medicine Researcher. This grant is for developing a major part of a gene therapy approach to safer and potentially curative treatments for hemophilia diseases. So different private and government organizations are investing in gene therapy for curing cancer diseases across the globe. Similarly, increasing demand for laboratory automation and growing awareness of preventative healthcare are the major factors that will boost the market growth over the years. The rise in cancer cases is primarily affecting the growth of the industry, being the second largest death cause in the world. In 2020, an estimated 1,806,590 new cases of cancer will be diagnosed in the United States, and 606,520 people will die from the disease.
The Global Cancer Gene Therapy Market can be segmented by therapy, indication, end user, and by region. Based on therapy, the market can be segmented into Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer, and Others. Based on indication, the market can be segmented into Breast Cancer, Ovarian Cancer, Lung Cancer, Liver Cancer, Pancreatic Cancer, Prostate Cancer, and Others. Based on the end user, the market can be differentiated by Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, and Others. Regionally, North America dominates the market among Asia Pacific, Europe, Middle East & Africa, and South America. Amongst the different countries, the United States dominates the global cancer gene therapy market on account of the growing demand for advanced therapy with low costs for curing cancer diseases in the country.
Abeona Therapeutics Inc., Asklepios BioPharmaceutical Inc., Altor Bioscience Inc., Bluebird bio-Inc., BioCancell Inc., Celgene Inc., Elevate Bio Inc., GlaxoSmithKline Inc., Genelux Corporation, Introgen Therapeutics Inc., OncoGenex Pharmaceuticals Inc., Merck KGaA are some of the leading players operating in the Global Cancer Gene Therapy Market.
In this report, global cancer gene therapy systems market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in Global Cancer Gene Therapy Market.
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: